Kaushik J. Dave Ph.D., MBA, President and Chief Executive Officer, hosted a call on to discuss recent progress and outline development plans for the Company's clinical stage products: Iomab-B and Actimab-A.
http://www.biospace.com/news_story.aspx?StoryID=316160&full=1
http://www.biospace.com/news_story.aspx?StoryID=316160&full=1
No comments:
Post a Comment